论文部分内容阅读
慢性阻塞性肺病(COPD)在人类死因结构中占3~4位。COPD包括慢性阻塞性支气管炎(COB)的发病率在所有发达国家始终增高。及时有效地治疗COB有巨大意义。本文报告作者用Berodual()治疗老年人COB的结果。共选择56例老年人COB病人为研究对象。平均年龄67.4岁±1.5岁,平均病程25.6±9.9年。对全部病人均用Berodual治疗,每次2气雾剂(1气雾剂含异丙阿托品0.02mg,酚丙喘宁0.05mg),每日4次吸入,疗程3周。对并发肺部感染的7例病人均合用大环内酯类抗生素治疗。在治疗开始前、治疗过程中和治
Chronic obstructive pulmonary disease (COPD) accounts for 3 to 4 of the human causes of death. The incidence of COPD, including chronic obstructive bronchitis (COB), has consistently increased in all developed countries. The timely and effective treatment of COB has great significance. This article reports the authors’ results of treating COB in the elderly using Berodual (). A total of 56 elderly patients with COB were selected as the research object. The average age of 67.4 years ± 1.5 years, the average duration of 25.6 ± 9.9 years. All patients were treated with Berodual, 2 aerosols each time (1 aerosol containing isopropylamine 0.02mg, phenprostin 0.05mg), 4 times a day inhalation, the course of 3 weeks. Seven patients with concurrent pulmonary infection were treated with macrolide antibiotics. Before treatment begins, during treatment and treatment